Skip to main content

The rockefeller university

News & HighlightsNews
New gene linked to severe cases of Fanconi anemia
Mutations in FANCX appear to cause a lethal form of Fanconi anemia, a finding that sheds light on unexplained pregnancy loss and offers new avenues for genetic screening.
Rockefeller honors decades of dedication
On Wednesday, April 30, The Rockefeller University honored members of its community who reached service milestones ranging from 10 to 45 years.
Svetlana Mojsov is elected to the National Academy of Sciences
Mojsov is a research associate professor whose research led to the development of drugs for obesity and diabetes.
Our ability to recognize objects depends on prior experience
New findings suggest neurons have much more functional dexterity than scientists previously realized.
Using a pea-sized node in the brain to potentially treat drug addiction
Ines Ibañez-Tallon is revealing how an understudied region of the brain plays an outsized role in opioid and nicotine dependence. 
Rockefeller University Press launches new journal in partnership with scientists
Open access, peer reviewed, and co-owned, the Journal of Human Immunity represents a new business model in scientific publishing.
Svetlana Mojsov honored with 2025 Breakthrough Prize
Mojsov is recognized for her discovery of the peptide hormone GLP-1, research that led to a new class of safe and highly effective drugs for type 2 diabetes as well as the treatment of obesity.
Two Rockefeller researchers chosen for the Chan Zuckerberg Biohub New York Investigator Program 
Kivanç Birsoy and Ekaterina Vinogradova will head projects that aim to harness and bioengineer immune cells for the early detection, prevention, and treatment of disease.
Clinical trials show new antibody therapy offers long-lasting HIV control without daily medication
Results presented at Conference on Retroviruses and Opportunistic Infections show that two broadly neutralizing antibodies can keep HIV suppressed for months.
Weill Cancer Hub East launched to unlock immunotherapy's full potential
This bold, multi-institutional collaboration will investigate how metabolism, diet, and gut microbes shape immune responses to cancer.
View
View